Jasper Closes Kira Deal, Extends Cash Runway
Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.
Jasper bought another company called Kira and raised $132 million in new money, which means it can keep operating longer without running out of cash. When companies do deals and get funding like this, it usually means they're working on new ideas, so watch if their medicine projects move forward.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.